SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-18-000827
Filing Date
2018-06-12
Accepted
2018-06-12 14:43:30
Documents
2
Period of Report
2018-06-08

Document Format Files

Seq Description Document Type Size
1 e618092_4-proteon.html 4  
1 e618092_4-proteon.xml 4 6991
2 e618092_ex99.htm EX-99 3632
  Complete submission text file 0001193805-18-000827.txt   12673
Mailing Address 780 THIRD AVENUE, 37TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017 2125511600
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (Reporting) CIK: 0001009258 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36694 | Film No.: 18894271

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Reporting) CIK: 0001352546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36694 | Film No.: 18894270

Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)